Abstract: This invention relates to a composite material which is a copolymer of at least (i) a functionalised carbon nanoparticle, (ii) a polyol, (iii) a compound comprising at least two isocyanate groups, wherein the functionalised carbon nanoparticle and the polyol are covalently bonded by a urethane and optionally a urea and/or an amide linkage, and a process for producing the same. Such composite materials are suitable for use in moulded articles for implantation within a mammal.

Abstract: A prosthesis delivery system comprises a sheath defining an axial direction; at least one tether movable axially relative to the sheath; and a holder movable axially within the sheath, configured to constrain radially the tether(s). Collapsing the prosthesis to a collapsed state in the sheath involves constraining radially with a holder the tether(s), attached to the prosthesis; and moving the tether(s) and the holder axially within the sheath such that the prosthesis is forced to collapse into the sheath and the holder is retracted into the sheath.

Abstract: A vascular implant comprises a structure defining a flow passage, the flow passage having a first end and a second end. The vascular implant is also provided with a skirt around at least a portion of the outer periphery of the structure. A portion of the skirt is fixed to the structure to form a seal with respect to the flow passage. The skirt is compliant such that, in response to a higher fluid pressure at one of the ends of the flow passage, the skirt is configured to be urged against the anatomy at the site in which the implant is located, to span between the outer periphery of the structure and said anatomy.

Abstract: A prosthesis delivery system comprises a sheath defining an axial direction; at least one tether movable axially relative to the sheath; and a holder movable axially within the sheath, configured to constrain radially the tether(s). Collapsing the prosthesis to a collapsed state in the sheath involves constraining radially with a holder the tether(s), attached to the prosthesis; and moving the tether(s) and the holder axially within the sheath such that the prosthesis is forced to collapse into the sheath and the holder is retracted into the sheath.

Abstract: A copolymer comprising (a) one or more pendant group segments and (b) one or more polyol segments, each of said segments being linked to one or more further segments which may be the same or different, wherein said one or more pendant group segments are the same or different and are selected from: (i) siloxane segments; (ii) segments containing phosphoryl choline or a derivative or analogue thereof; (iii) segments containing a di- or trifluoromethyl group; (iv) heparin-like segments containing a group of formula (XII) D-N?N—Ar—SO3???(XII) wherein D is an aliphatic or aromatic group and Ar—SO3? comprises one or more linked aryl and/or heteroaryl groups, at least one of the aryl and/or heteroaryl groups having an SO3? substituent; and (v) segments containing a group of formula (I) [P]n?-[Lys]n-Lys-[Spacer]-Lys-[Al]x??(I) wherein: [Al] is an inert amino acid; x is 0, 1, 2 or 3; [Spacer] is a fatty acid, amino acid, peptide or PEG; [P]n?-[Lys]n is a dendritic structure formed from n lysine groups and term

Abstract: A copolymer comprising (a) one or more pendant group segments and (b) one or more polyol segments, each of said segments being linked to one or more further segments which may be the same or different, wherein said one or more pendant group segments are the same or different and are selected from: (i) siloxane segments; (ii) segments containing phosphoryl choline or a derivative or analogue thereof; (iii) segments containing a di- or trifluoromethyl group; (iv) heparin-like segments containing a group of formula (XII) D-N?N—Ar—SO3? ??(XII) wherein D is an aliphatic or aromatic group and Ar—SO3? comprises one or more linked aryl and/or heteroaryl groups, at least one of the aryl and/or heteroaryl groups having an SO3? substituent; and (v) segments containing a group of formula (I) [P]n?-[Lys]n-Lys-[Spacer]-Lys-[Al]x ??(I) wherein: [Al] is an inert amino acid; x is 0, 1, 2 or 3; [Spacer] is a fatty acid, amino acid, peptide or PEG; [P]n?-[Lys]n is a dendritic structure formed from n lysine group

Abstract: The present invention relates to the use of ruthenium and osmium complexes as catalysts, preferably for bonding peptides to the surfaces of polymers, especially polymers for use as prosthetic materials in surgery, such as polymers for use as blood vessel grafts.